Watch Demo

Sweden Anti-Infective Industry Outlook 2024 - 2028

See how Sweden Anti-Infective performed compared to key markets such as Italy, Spain and Croatia.

Key Market Indicators

Swedish Antiinfective Medicine Sales are projected to reach approximately $399 million by 2028, up from around $392 million in 2023. This represents a modest annual growth rate of 0.3%. However, since 2005, the Swedish market has seen a decline, shrinking by 5.6% annually. In the 2023 rankings, Sweden was the seventh-largest market, with Belgium surpassing it at approximately $392 million. The top three spots were occupied by Spain, Croatia, and Australia, respectively. In terms of antibiotics import, Sweden is expected to see a decline. By 2028, the import value is forecasted to drop to nearly $5.8 million from about $6.1 million in 2023, reflecting an average annual decrease of 0.9%. Since 1997, the demand for antibiotics in Sweden has decreased by 0.5% each year. On the export front, Swedish antibiotics saw a significant boost. In 2018, exports were close to $302,000, up from $226,000 in 2017, marking a substantial 33.5% year-on-year increase. Since 1997, Swedish antibiotic supply has grown by an average of 25.3% annually.

Marketing Banner

Sweden Anti-Infective Market Data and Forecasts